Progress and Key Initiatives of the Mid-term Strategy Accelerate 2030｜May 2026

Review of Business Strategy and Key Initiatives

Daxcel reviews the progress of Accelerate 2030 and continues to focus on strengthening its business and expanding investments as key initiatives to drive growth. The company aims to grow in the fields of medical devices, health foods, and environmentally sustainable materials, emphasizing market expansion domestically and internationally. It promotes new investments and research & development to enhance competitiveness, while also optimizing existing operations and improving profitability.

Future Goals and Key Initiatives

To accelerate growth beyond 2026, Daxcel is pursuing diversification and global expansion, with a particular focus on growth in the China and India markets. The company plans to strengthen investments and R&D efforts to expand sales and profits, aiming for sales of 675.0 billion yen and an operating income margin of over 15% by 2030. It actively addresses social issues such as environmental sustainability and next-generation development, pursuing sustainable growth.